¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (2ÀÏÂ÷) : 2022-03-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (2ÀÏÂ÷) : 2022-03-25
±³À°ÀÏÀÚ : 2022-03-25
±³À°Àå¼Ò : ¼­¿ï ÄÚ¿¢½º  
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) 2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (2ÀÏÂ÷) 
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¾¾çÇÐȸ(ÀÎ)
´ã´çÀÚ : »ç¹«±¹
¿¬¶ôó : 02-3452-0507  
À̸ÞÀÏ : office@wfnos2022.org      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 30 ½Ã°£ 5ºÐ  
¼¼ºÎ¼ö°­·á : 720,000¿ø      
ºñ°í WFNOSȸ¿ø±âÁØ »çÀüµî·Ï USD 500 / ÇöÀåµî·Ï USD 600      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-25 Auditorium, 3F 07:00~07:20 Metabolic heterogeneity of glioma stem cells  Hideyuki Saya(Keio University Japan) 
±³À°½Ã°£ 03-25 Auditorium, 3F 07:20~07:40 Mechanisms for Intra-tumoral Heterogeneity Unraveled in Novel Models for Pediatric Gliomas  Claudia K. Petritsch(Stanford University USA) 
±³À°½Ã°£ 03-25 Auditorium, 3F 07:40~08:00 Cancer stem cells in ependymoma: role of YAP1 and TEAD  Daisuke Kawauchi(National Institute of Neuroscience National Center of Neurology and Psychiatry Japan) 
±³À°½Ã°£ 03-25 GBR 101+102 07:00~07:20 Motor mapping in glioma surgery  Frederick F. Lang(M. D. Anderson Cancer Center USA) 
±³À°½Ã°£ 03-25 GBR 101+102 07:20~07:40 Language and cognitive mapping in glioma surgery  Hugues Duffau(Montpellier University Medical Center France) 
±³À°½Ã°£ 03-25 GBR 101+102 07:40~08:00 Awake craniotomy for insula gliomas  Jinsong Wu(Fudan University China) 
±³À°½Ã°£ 03-25 GBR 103, 1F 07:00~07:20 Brain tumors—Imaging surrogates of molecular genetic signature  Soonmee Cha(University of California San Francisco USA) 
±³À°½Ã°£ 03-25 GBR 103, 1F 07:20~07:40 Imaging Updates for Genetic Mutation and Tissue Proliferation (AI, 2HG and APT)  Ji Eun Park(Asan Medical Center) 
±³À°½Ã°£ 03-25 GBR 103, 1F 07:40~08:00 Application of Arterial Spin Labeling in Brain Tumor  Tae Jin Yun(Seoul National University) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 07:00~07:20 Novel treatment strategy of Pediatric LGG  Jason Fangusaro(Children¡¯s Healthcare of Atlanta Emory University USA) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 07:20~07:40 Druggable targets in pediatric and adolescent HGG  Chris Jones(The institute of Cancer Research UK) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 07:40~08:00 DIPG in children and adolecents  Chris Jones(The institute of Cancer Research UK) 
È޽Ġ03-25  08:00~08:15 Break  () 
±âŸ 03-25 Auditorium, 3F 08:15~08:25 Opening Ceremony  () 
±³À°½Ã°£ 03-25 Auditorium, 3F 08:25~08:55 Keynote Lecture EANO  Michael Platten(German Cancer Research Center (DKFZ) & Mannheim University Hospital Germany) 
±³À°½Ã°£ 03-25 Auditorium, 3F 08:55~09:35 Communicating networks in brain tumors, and its clinical implications  Frank Winkler(Heidelberg University and German Cancer Research Center Germany) 
±³À°½Ã°£ 03-25 Auditorium, 3F 09:35~10:15 Neuronal regulation of glioma progression  Michelle Monje(Stanford University USA) 
±³À°½Ã°£ 03-25 Auditorium, 3F 10:15~10:30 A phase I first-in-human trial with local application of CAR-NK cells targeting HER2 in patients with recurrent glioblastoma (CAR2BRAIN): Results of the dose-escalation cohort  Michael C Burger(Goethe University Hospital Frankfurt Germany) 
±³À°½Ã°£ 03-25 Auditorium, 3F 10:30~10:45 Extra-chromosomal DNA (ecDNA) do not necessarily cluster or interact with condensates in Glioblastoma Stem Cells  Karin Purshouse(University of Edinburgh UK) 
±³À°½Ã°£ 03-25 Auditorium, 3F 10:45~11:00 Inhibition of mutant IDH1 increases T-cell infiltration and synergizes with immune checkpoint inhibition in a humanized glioma mouse model  Khwab Sanghvi(German Cancer Research Center (DKFZ) Heidelberg Germany) 
±³À°½Ã°£ 03-25 Auditorium, 3F 11:00~11:15 Tirabrutinib, a second-generation BTK inhibitor in relapsed and refractory primary CNS lymphoma: A single institute study  Kazuhiko Mishima(Saitama Medical University International Medical Center Japan) 
±³À°½Ã°£ 03-25 Auditorium, 3F 11:15~11:30 Novel Patient-Derived Xenograft and Cell Line models for Therapeutic Screening in NF2-associated Schwannoma  Fu Zhao(Beijing Tiantan hospital China) 
È޽Ġ03-25  11:30~11:50 Break  () 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 11:50~12:10 Circumscribed Glioma  Tarik Tihan(University of California San Francisco USA) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 12:10~12:30 Glioneuronal tumor  Takashi Komori(Tokyo Metropolitan Neurological Hospital Japan) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 12:30~12:50 Ependymoma  Torsten Pietsch(University of Bonn Germany) 
±³À°½Ã°£ 03-25 GBR 103, 1F 11:50~12:10 RANO Criteria for High Grade and Low Grade Gliomas  Eudocia Q Lee(Harvard Medical School USA) 
±³À°½Ã°£ 03-25 GBR 103, 1F 12:10~12:30 RANO Criteria for Brain Metastases and Leptomeningeal Metastases  Hidefumi Aoyama(Hokkaido University Japan) 
±³À°½Ã°£ 03-25 GBR 103, 1F 12:30~12:50 Neurologic Assessment in Neuro-Oncology (NANO) Scale  Enrico Franceschi(Bellaria Hospital Italy) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 11:50~12:10 Primary SRS with temozolomide  Antonio Omuro(Yale Brain Tumor Center Yale University USA) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 12:10~12:30 Advances in adjuvant and salvage SRS  Yoshua esquenazi(University of Texas health science Center USA) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 12:30~12:50 Novel treatments combined with SRS  Frank Anton Giordano(University Medical Center Mannheim Germany) 
È޽Ġ03-25  12:50~13:10 Break  () 
±³À°½Ã°£ 03-25 Auditorium, 3F 13:10~13:30 The 2021 WHO Classification of CNS Tumors  David Louis(Harvard Medical School USA) 
±³À°½Ã°£ 03-25 Auditorium, 3F 13:30~13:40 Molecular characterization of adult cerebellar glioblastomas identifies distinct prognostic subs  Thiebaud Picart(Hospices Civils de Lyon France) 
±³À°½Ã°£ 03-25 Auditorium, 3F 13:40~13:50 Low Expression of DYNLT3 Predicts better prognosis for Female Glioblastoma Patients  Yuanjun Hu(Sun Yat-sen Cancer Center China) 
±³À°½Ã°£ 03-25 Auditorium, 3F 13:50~14:00 FXYD2 mRNA expression represents a new independent factor that affects survival of glioma patients and predicts chemosensitivity of patients to temozolomide  Zhou Kajia(Fujian Cancer Hospital & Fujian Medical University Cancer Hospital China) 
±³À°½Ã°£ 03-25 Auditorium, 3F 14:00~14:10 PDGFRA amplification is a significant prognostic marker in patients with IDH wild-type glioblastoma multiforme  Koji Yoshimoto(Graduate School of Medical and Dental Sciences Kagoshima University Japan) 
±³À°½Ã°£ 03-25 Auditorium, 3F 14:10~14:20 Comprehensive molecular subing of pleomorphic xanthoastrocytomas (PXA)  Prerana Jha(Karkinos Healthcare India) 
±³À°½Ã°£ 03-25 Auditorium, 3F 14:20~14:30 High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: A glimmer of hope?  Wanming Hu(Sun Yat-sen University Cancer Center China) 
±³À°½Ã°£ 03-25 Auditorium, 3F 14:30~14:40 Molecular and clinical features of patients with glioblastoma treated with targeted therapy at Johns Hopkins Medicine  Michael Chang(Johns Hopkins University School of Medicine Baltimore USA) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 13:10~13:30 The rationale and methods to achieve a safe, maximal glioma resection  Mitchel Berger(University of California USA) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 13:30~13:40 Impact of First-Line Surgical Treatment of Low-Grade Glioma on Mental Health Disorder On  Debarati Bhanja(Penn State College of Medicine USA) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 13:40~13:50 Incorporating diffusion- and perfusion-weighted MRI radiomics to clinical features improves prediction of survival in patients with lower-grade gliomas  Chae Jung Park(Yongin Severance Hospital Yonsei University College of Medicine) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 13:50~14:00 Prognostic Relevance of Adding Radiomics to the WHO 2021 Updates for IDH-Wildtype Lower-grade Gliomas with Known EGFR Amplification and TERT Promoter Mutation Status  Yae Won Park(Severance Hospital Yonsei University College of Medicine) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 14:00~14:10 Diffuse hemispheric glioma, H3G34-mutant: Distinctive clinicopathological features  Sridhar Epari(Tata Memorial Hospital and ACTREC Tata Memorial Centre Homi Bhabha National Institute India) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 14:10~14:20 Systematic Review - Time to Malignant Transformation in Low Grade Gliomas: Predicting a catastrophic event with clinical, neuroimaging and molecular markers  Zabina Satar(The National Hospital for Neurology and Neurosurgery University College London UK) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 14:20~14:30 Anlotinib alone or in combination with temozolomide in recurrent high-grade glioma: a retrospective analysis  Qunying Yang(Sun Yat-Sen University Cancer Center China) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 14:30~14:40 Mood disorder, Health Related Quality of Life and Sexual life disturbances in glioma patients: prevalence and putative factors  Guglielmo Puglisi(University of Milan Italy) 
±³À°½Ã°£ 03-25 GBR 103, 1F 13:10~13:30 Target combine with immunotherapy: Is a hope for glioma treatment?  Zhong-Ping Chen(Sun Yat-sen University China) 
±³À°½Ã°£ 03-25 GBR 103, 1F 13:30~13:40 A glioneuronal tumor with CLIP2-MET fusion  Tamrin Chowdhury(Seoul National University College of Medicine) 
±³À°½Ã°£ 03-25 GBR 103, 1F 13:40~13:50 MYCN-driven retinoblastoma originates in death-resistant retinal progenitor of cone photoreceptors and horizontal cells  Dardan Konjusha(Uppsala University Sweden) 
±³À°½Ã°£ 03-25 GBR 103, 1F 13:50~14:00 Intracranial solitary fibrous tumor/hemangiopericytoma: tumor reclassification and assessment of treatment outcome via the 2016 WHO classification  Dongwon Shin(Asan Medical Center University of Ulsan College of Medicine) 
±³À°½Ã°£ 03-25 GBR 103, 1F 14:00~14:10 Sporadic Solid/cystic Hemangioblastomas in the Cerebellum£º Retrospective Study in a Single Center  Xia Haijian(The First Affiliated Hospital of Chongqing Medical University China) 
±³À°½Ã°£ 03-25 GBR 103, 1F 14:10~14:20 Apparent diffusion coefficient as a prognostic factor in clival chordoma  Hyeong Cheol Oh(Gangnam Severance Hospital Yonsei University College of Medicine) 
±³À°½Ã°£ 03-25 GBR 103, 1F 14:20~14:30 Posterior fossa ependymomas: Evaluation of H3K27me3 expression and 1q gains  Janani A(Tata Memorial Hospital and ACTREC Tata Memorial Centre Homi Bhabha National institute India) 
±³À°½Ã°£ 03-25 GBR 103, 1F 14:30~14:40 Single-cell RNA-seq of Supratentorial Ependymoma Reveals Distinctive Cellular Architecture Amongst Molecular Subs  Daeun Jeong(Dana Farber Cancer Institute USA) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 13:10~13:30 Dissecting intra-tumor heterogeneity in glioma  Itay Tirosh(Weizmann Institute of Science Israel) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 13:30~13:40 Biological characteristics comparison of glioblastoma tumorsphere obtained the fresh and cryopreservation sample  Min Kyun Na(Hanyang University Medical Center) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 13:40~13:50 Loss of PrPC modulates expression and localization of stemness markers in Glioblastoma stem-like cells  Mariana Brandao Prado(Institute of Medical Sciences University of Sao Paulo Brazil) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 13:50~14:00 Disrupting Inhibitory Feeack Mediated by ¥â-catenin Reinforces cAMP-induced Differentiation in Glioma Stem Cells  Ke Sai(Sun Yat-sen University Cancer Center China) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 14:00~14:10 Sema3C Signaling Confers Resistance to Wnt Inhibition in Glioblastoma  Jennifer Yu(Cleveland Clinic USA) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 14:10~14:20 Silencing of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived a de novo murine brain cancer model  Seisuke Tanigawa(Kyoto Pharmaceutical University Japan) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 14:20~14:30 The specific FGFR inhibitor INCB054828 (Pemigatinib) radiosensizes unmethylated MGMT glioblastoma cells and Glioblastoma stem cells.  Elizabeth Cohen-Jonathan Moyal(Institut Claudius Regaud IUCT-Oncopole France) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 14:30~14:40 Local tumor after surgical resection arises subventricular zone via CXCL12/CXCR4 axis in the glioblastoma  Xue Li(Seoul National University Hospital) 
±³À°½Ã°£ 03-25 Auditorium, 3F 14:40~15:00 Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial  Wolfgang Wick(University of Heidelberg Germany) 
±³À°½Ã°£ 03-25 Auditorium, 3F 15:00~15:20 Predictive biomarkers for bevacizumab response in newly-diagnosed glioblastoma  Ryo Nishikawa(Saitama Medical University Japan) 
±³À°½Ã°£ 03-25 Auditorium, 3F 15:20~15:40 Challenges and opportunities for drug development in newly diagnosed GBM  Roger Stupp(Northwestern University USA) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 14:40~15:00 360 degree approaches to the skull base tumors  James Liu(Rutgers University USA) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 15:00~15:20 Endoscopic endonasal surgery for skull base tumors  Calvin Mak(Queen Elizabeth Hospital Hong Kong) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 15:20~15:40 Endoscopic endonasal supraoptic and infraoptic approaches for the complex ¡°para-suprasellar¡± lesions£ºsurgical anatomy, technique nuances, and case series  Tao Hong(The First Affiliated Hospital of Nanchang University China) 
±³À°½Ã°£ 03-25 GBR 103, 1F 14:40~15:00 Epigenetic regulation in cancer genesis  Chan Chung(Daegu Gyeongbuk Institute of Science and Technology (DGIST)) 
±³À°½Ã°£ 03-25 GBR 103, 1F 15:00~15:20 Epigenetic regulation in glioblastomas  Antonio Iavarone(Columbia University USA) 
±³À°½Ã°£ 03-25 GBR 103, 1F 15:20~15:40 RNA interferences in glioma genesis  Houtan Noushmehr(Hermelin Brain Tumor Center & Henry Ford Health System USA) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 14:40~15:00 Aggressive embryonal brain tumors - Challenges in treatment versus science  Wan-Yee Teo(Duke-NUS Medical School Singapore) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 15:00~15:20 Salvage chemotherapy of relapsed medulloblastoma  Keita Terashima(National Center for Child Health and Development Japan) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 15:20~15:40 The role of radiotherapy in relapsed medulloblastoma  Do Hoon Lim(Samsung Medical Center) 
È޽Ġ03-25  15:40~16:00 Break  () 
±³À°½Ã°£ 03-25 Auditorium, 3F 16:00~16:20 INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFRamplified glioblastoma  Martin van den Bent(Erasmus MC Cancer Institute The Netherlands) 
±³À°½Ã°£ 03-25 Auditorium, 3F 16:20~16:40 Featured clinical trials for recurrent glioblastoma: viroimmunotherapy  Frederick F. Lang(M. D. Anderson Cancer Center USA) 
±³À°½Ã°£ 03-25 Auditorium, 3F 16:40~17:00 Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systematic immune responses in recurrent glioblastoma  Patrick Wen(Harvard Medical School USA) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 16:00~16:20 Gene-drug screening for precision neuro-oncology  Do-hyun Nam(Samsung Medical Center Sungkyunkwan University) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 16:20~16:40 Energy and Protein Starvation to Circumvent Glioma Heterogeneity  Vinay Puduvalli(M. D. Anderson Cancer Center USA) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 16:40~17:00 The genomic landscape of glioma in adult patients  Roel Verhaak(Jackson Laboratory for Genomic Medicine USA) 
±³À°½Ã°£ 03-25 GBR 103, 1F 16:00~16:20 Evaluation of tumor habitat: Application of Radiomic Methods in Neuro Oncology  Raymond Huang(Harvard Medical School USA) 
±³À°½Ã°£ 03-25 GBR 103, 1F 16:20~16:40 Imaging spatiotemporal heterogeneity of treated glioblastoma: longitudinal assessment of subregional habitats using multiparametric MRIs  Ho Sung Kim(Asan Medical Center) 
±³À°½Ã°£ 03-25 GBR 103, 1F 16:40~17:00 Understanging microenviroment of brain tumors using imaging modatlities  Seung Hong Choi(Seoul National University) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 16:00~16:20 Racial differences in glioma risk  Melissa Bondy(Stanford University USA) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 16:20~16:40 Genetic predisposition for gliomagenesis  Robert B. Jenkins(Mayo Clinic USA) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 16:40~17:00 Genetic and metabolic risk factors for glioma development  Beatrice Melin(Umea University Sweden) 
±³À°½Ã°£ 03-25 Auditorium, 3F 17:00~17:20 Practical approaches towards CNS tumor diagnosis using methylation profiling and machine learning  Kenneth Aldape(Princess Margaret Cancer Centre Canada) 
±³À°½Ã°£ 03-25 Auditorium, 3F 17:20~17:30 Distinct invasive pathways are driven by major oncogenetic drivers in glioblastoma  Emil Rosen(Uppsala University Sweden) 
±³À°½Ã°£ 03-25 Auditorium, 3F 17:30~17:40 Breaching the blood brain barrier (BBB) by Tumor Treating Fields (TTFields) could be a novel chemotherapeutic delivery strategy  Carsten Hagemann(University Hospital Würzburg Germany) 
±³À°½Ã°£ 03-25 Auditorium, 3F 17:40~17:50 Single-cell tranomic and epigenomic immune landscape of human gliomas  Krishna Bhat(University of Texas MD Anderson Cancer Center USA) 
±³À°½Ã°£ 03-25 Auditorium, 3F 17:50~18:00 Inhibition of PI3K restores cancer cell sensitivity to Tumor Treating Fields (TTFields)  Moshe Giladi(Novocure Israel) 
±³À°½Ã°£ 03-25 Auditorium, 3F 18:00~18:10 Growth Hormone Receptor (GHR) is overexpressed in low EGFR expressing glioblastoma and promotes tumor growth  Irma Segoviano Vilchis(Sorbonne Université Institut du Cerveau - Paris Brain Institute - ICM Inserm CNRS APHP Hôpital de la Pitié Salpêtrière Paris France) 
±³À°½Ã°£ 03-25 Auditorium, 3F 18:10~18:20 Tranomic analysis reveals novel Tumour Microenvironment subtypes in IDH wildtype Glioblastoma  Kieron White(Royal College of Surgeons in Ireland Ireland) 
±³À°½Ã°£ 03-25 Auditorium, 3F 18:20~18:30 Proteomic analysis predicts anti-angiogenic resistance in the recurred IDH-wild type glioblastoma  Hanwool Jeon(Asan Medical Center University of Ulsan College of Medicine) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 17:00~17:20 Importance of functional anatomy in glioma surgery  Marcos Maldaun(The Syrian-Lebanese Hospital Brazil) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 17:20~17:30 Deep white matter portion of dorsal superior longitudinal fascicle is a critical region for preservation of visuospatial cognition during glioma surgery  Mitsutoshi Nakada(Kanazawa University Japan) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 17:30~17:40 Resection of supplementary motor area gliomas: revisiting supplementary motor syndrome and the role of the frontal aslant tract  Andrew Gogos(St Vincents Hospital Melbourne Australia) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 17:40~17:50 Standardized reporting of adverse events and functional status the first 5 years of awake-surgery for gliomas: a population-based single-institution consecutive series  Margret Jensdottir(Karolinska University Hospital Sweden) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 17:50~18:00 Usefulness of intraoperative PDD under 5-ALA istration in brain tumors  Ryokichi Yagi(Osaka Medical and Pharmaceutical University Japan) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 18:00~18:10 Development of novel topical fluorescent probe for intraoperative rapid detection of glioma  Shota Tanaka(The University of Tokyo Japan) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 18:10~18:20 Patterns of recurrence according to the extent of resection in patients with IDH-wildtype glioblastoma: a retrospective study  Jihwan Yoo(Gangnam Severance Hospital Yonsei University College of Medicine) 
±³À°½Ã°£ 03-25 GBR 101+102, 1F 18:20~18:30 Stereotactic biopsy for adult brainstem lesions: a surgical approach and its diagnostic value according to the 2016 World Health Organization Classification  In-Ho Jung(Severance Hospital Yonsei University College of Medicine) 
±³À°½Ã°£ 03-25 GBR 103, 1F 17:00~17:20 The use of skull implantable ultrasound for delivery of chemotherapy, results a phase 1 clinical trial  Adam Sonabend(Northwestern University Feinberg USA) 
±³À°½Ã°£ 03-25 GBR 103, 1F 17:20~17:30 Human bone-marrow derived mesenchymal stromal cells increase glioblastoma radioresistance  Maren Strack(Medical Center - University of Freiburg Germany) 
±³À°½Ã°£ 03-25 GBR 103, 1F 17:30~17:40 Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle  Hong In Yoon(Yonsei Cancer Center Yonsei University College of Medicine) 
±³À°½Ã°£ 03-25 GBR 103, 1F 17:40~17:50 Tissue factor promotes oncogenic senescence signaling and radiation resistance in glioblastoma.  Hye-Min Jeon(Lerner Research Institute Cleveland Clinic USA) 
±³À°½Ã°£ 03-25 GBR 103, 1F 18:10~18:20 Deep Learning Radiomics to Predict PTEN Mutation Status From Magnetic Resonance Imaging in Patients With Glioma  Hongyu Chen(State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat-sen University Cancer Center China) 
±³À°½Ã°£ 03-25 GBR 103, 1F 18:20~18:30 Interpretable machine learning model for prediction of prognosis in patients with glioblastoma  Wonmo Sung(College of Medicine The Catholic University of Korea) 
±³À°½Ã°£ 03-25 GBR 103, 1F 17:50~18:00 Volumetric change in brain cortex and gray matter after radiotherapy in glioma patients detected with longitudinal magnetic resonance imaging  Hye In Lee(Seoul National University Hospital) 
±³À°½Ã°£ 03-25 GBR 103, 1F 18:00~18:10 Quantitative Cerebral Blood Volume Images synchesis Standard MRI Using Generative Adversarial Network: A Single Center Data of 756 Scans  Yingchao Liu(Provincial Hospital Affiliated to Shandong First Medical University China) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 17:00~17:20 Thromboembolism in patients with brain tumours  James Perry(University of Toronto Canada) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 17:20~17:30 Short-term outcome following surgery for rare brain tumor entities in adults: a Swedish nation-wide registry-based study and comparison with SEER database  Jiri Bartek(Karolinska University Hospital Sweden) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 17:30~17:40 Questionnaire survey regarding working condition of the members belongs to the Japan Society for Neuro-Oncology (JSNO) by the Gender Equality and Diversity Committee of the JSNO 2021  Takamitsu Fujimaki(Gender equality and diversity committee of the Japan Society for Neuro-oncology Japan) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 17:40~17:50 Primary brain tumor research productivity in Southeast Asia and its association with socioeconomic determinants and burden of disease  Mark Willy Mondia(Philippine General Hospital Philippines) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 17:50~18:00 Perception of Uncertainty Concerning Illness and Coping Styles among Parents of Children with Central Nervous System Tumors: a Correlation Analysis  Lan Bai(Sun Yat-sen University Cancer Center China) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 18:00~18:10 Treatment of 148 cases of intracranial germ cell tumors, dynamic monitoring of lymphocyte subs and related prognosis  Hairong Wang(Sun Yat-sen Universiy Cancer Center China) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 18:10~18:20 Rare germline variants in the tumor suppressor gene CDH1 in glioma families and gastric cancer families with brain tumors  Ruthild G. Weber(Hannover Medical School Germany) 
±³À°½Ã°£ 03-25 GBR 104+105, 1F 18:20~18:30 TTF-1: a well-favoured addition to the immunohistochemistry armamentarium as a diagnostic marker of SEGA  Rimlee Dutta(All India Institute of Medical Sciences New Delhi India) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022 ´ëÇѽŰæÁ¾¾çÇÐȸ Ãá°èÇмú´ëȸ ¹× Á¦6Â÷ ¼¼°è½Å°æÁ¾¾çÇÐȸ Çмú´ëȸ (2ÀÏÂ÷) : 2022-03-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ (¿Â¶óÀÎ) Á¦16Â÷ GLAM(Guidelines for Lipid and Atherosclerosis Management) ¿¬¼ö±³À° ÇÁ·Î±×·¥ : 2022-03-25
´ÙÀ½±Û ´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) The 5th KSN-Live Academy : 2022-03-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 43 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 34 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 35 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 43 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 36 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 27 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 8 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 11 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 25 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 13 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 11 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 29 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 17 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 25 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 21 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷